SU-14813
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SU-14813, covering 2011-08-08 to 2011-08-08. Get the full timeline:
Most recent: Clinical Trial Update: A Trial Of SU14813 In Patients With Advanced Solid Malignancies [Phase 1]